Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature
Clinical trial NCT03061539 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03061539
- Sponsor
- University College, London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2022-06-20
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.